规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | MAO ↓ ↑ | MAO-A ↓ ↑ | MAO-B ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sennoside A |
++
MAO, IC50: 17 μM |
98%+ | |||||||||||||||||
Glycyrrhizic acid |
++++
MAO, IC50: 0.16 μM |
80% HPLC | |||||||||||||||||
Rasagiline |
++++
MAO-A, IC50: 412 nM |
++++
MAO-B, IC50: 4.43 nM |
97% | ||||||||||||||||
Isatin |
++
MAO, IC50: 15 μM |
+
MAO-A, IC50: 58 μM |
++
MAO-B, IC50: 14 μM |
98% | |||||||||||||||
Paeonol |
+
MAO-A, IC50: 54.6 μM |
+
MAO-B, IC50: 42.5 μM |
98% | ||||||||||||||||
Tranylcypromine hydrochloride |
+++
MAO-A, IC50: 11.5 μM |
+++
MAO-B, IC50: 7 μM |
97% | ||||||||||||||||
Moclobemide |
+++
MAO-A (5-HT), IC50: 6.1 μM |
99%+ | |||||||||||||||||
Pargyline HCl |
++
MAO-A, Ki: 13 μM |
+++
MAO-B, Ki: 0.5 μM |
99%+ | ||||||||||||||||
Safinamide |
++++
MAO-B, IC50: 98 nM |
98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | Minaprine dihydrochloride is a reversible inhibitor of MAO-A, also weakly inhibits acetylcholinesterase and is an antidepressant for treatment of depression. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00940823 | - | Completed | - | - | |
NCT03499964 | Urethral Stricture | Not Applicable | Recruiting | November 2024 | United States, Arkansas ... 展开 >> Arkansas Urology Recruiting Little Rock, Arkansas, United States, 72211 Contact: Katie O'Brien Principal Investigator: Richard D'Anna, MD Sub-Investigator: Keith Mooney, MD Sub-Investigator: Edwin Diaz, MD Sub-Investigator: Jeffrey Marotte, MD Sub-Investigator: Megan Thomas, APRN United States, Colorado Urology Associates, P.C. Recruiting Englewood, Colorado, United States, 80113 Contact: Lenden Neeper Contact: Michelle Lexin Principal Investigator: Barrett Cowan, MD United States, Florida Advanced Urology Institute Recruiting Daytona Beach, Florida, United States, 32114 Contact: Jonelle Horsley Principal Investigator: Jeffrey Dann, MD United States, Maryland Chesapeake Urology Recruiting Hanover, Maryland, United States, 21076 Contact: Wendy Paxton Principal Investigator: Kaiser Robertson, MD Sub-Investigator: Robert Goldfarb, MD Chesapeake Urology Research Recruiting Towson, Maryland, United States, 21204 Contact: Jacqueline Burmer Principal Investigator: Richard Levin, MD Sub-Investigator: Ronald Tutrone, MD United States, Minnesota University of Minnesota Department of Urology Not yet recruiting Minneapolis, Minnesota, United States, 55445 Contact: Bethany Marlette Principal Investigator: Sean Elliott, MD United States, New Jersey Delaware Valley Urology Recruiting Voorhees, New Jersey, United States, 08043 Contact: Brianna Florentine Principal Investigator: David Sussman, DO United States, New York Western New York Urology Associates Recruiting Cheektowaga, New York, United States, 14225 Contact: Margaret Scott Contact: Thomasina Smith Principal Investigator: Kent Chevli, MD Sub-Investigator: Peter Walter, MD Columbia University Medical Center/New York-Presbyterian Hospital Not yet recruiting New York, New York, United States, 10032 Contact: Debduth Pijush Principal Investigator: Steven Brandes, MD Iris Cantor Men's Health Center Recruiting New York, New York, United States, 10065 Contact: Dominique Thomas Principal Investigator: Alexis Te, MD United States, Oregon Oregon Urology Institute Recruiting Springfield, Oregon, United States, 97477 Contact: Danna Cardenas Principal Investigator: David DiMarco, MD Sub-Investigator: Brian Mehlaff, MD United States, South Carolina Carolina Urology Partners Recruiting West Columbia, South Carolina, United States, 29169 Contact: Pam Tims Contact: Kristin Kennedy Principal Investigator: Brian Willard, MD Sub-Investigator: David Lamb, MD Sub-Investigator: Keith Brightbill, MD Sub-Investigator: Griffin Morrisson, MD United States, Texas Urology San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Jeannette Cruz Principal Investigator: Christopher Cantrill, MD Sub-Investigator: Daniel Saltzstein, MD Sub-Investigator: Clayton Hudnall, MD Sub-Investigator: Davie Talley, MD United States, Virginia Urology of Virginia Recruiting Virginia Beach, Virginia, United States, 23462 Contact: Daniel Bekong Principal Investigator: Ramon Virasoro, MD Sub-Investigator: Jessica DeLong, MD Sub-Investigator: Jeremy Tonkin, MD Sub-Investigator: Kurt McCammon, MD United States, Washington University of Washington Harborview Medical Center Recruiting Seattle, Washington, United States, 98104 Contact: Michael Donahue Principal Investigator: Judith Hagedorn, MD Sub-Investigator: Neils Johnsen, MD 收起 << |
NCT00852852 | Cancer | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Washington University of Washington Medical Center Seattle, Washington, United States, 98115 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.69mL 0.54mL 0.27mL |
13.47mL 2.69mL 1.35mL |
26.93mL 5.39mL 2.69mL |
CAS号 | 25953-17-7 |
分子式 | C17H24Cl2N4O |
分子量 | 371.305 |
别名 | |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere,Room Temperature |
溶解方案 |
DMSO: 105 mg/mL(282.79 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 100 mg/mL(269.32 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |